(Reuters) -Telehealth company Ro has enlisted former tennis player Serena Williams as a celebrity patient ambassador for its weight-loss treatments, it said on Thursday. She will star in a national ...

The Vanity Fair Oscar after-party is always a star-studded affair, and this year’s celebration at the Wallis Annenberg Center for the Performing Arts in Beverly Hills was no exception.

Canadian YouTuber and comedian Lilly Singh will feature in the Netflix original 'Best of the Best', penned by Hasan Minhaj ...

Lilly plans to sell its production site in Branchburg, New Jersey, as part of a broader production overhaul at the company, a spokesperson confirmed.

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.

Eli Lilly is pivoting its pain pipeline, punting a midstage program it licensed from Centrexion Therapeutics while adding a candidate from its recent SiteOne Therapeutics buyout to its ea | Eli ...

Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight in a late-stage study, but that was less than previous trial results for Novo Nordisk's ...

Eli Lilly (NYSE:LLY) is set to release its earnings on Thursday, August 7, 2025. In the past, Eli Lilly’s stock has displayed a pattern of negative one-day returns following earnings announcements.

Eli Lilly reported second quarter earnings Thursday, a day after competitor Novo Nordisk missed earnings estimates by Wall Street.

With the next generation of drugs in development amidst an ever-changing environment, here’s what we think of Lilly stock.

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial saw people lose 12% of body weight.

Eli Lilly’s blockbuster diabetes drug Mounjaro matched the ability of an older treatment to prevent major heart complications in a large trial.